Goldman Sachs’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.11M | Sell |
74,441
-29,267
| -28% | -$1.99M | ﹤0.01% | 3859 |
|
|
2026
Q1 | $7.77M | Buy |
103,708
+10,307
| +11% | +$844K | ﹤0.01% | 3280 |
|
|
2025
Q4 | $7.29M | Buy |
93,401
+5,200
| +6% | +$422K | ﹤0.01% | 3388 |
|
|
2025
Q3 | $7.49M | Buy |
88,201
+47,162
| +115% | +$3.78M | ﹤0.01% | 3263 |
|
|
2025
Q2 | $3.21M | Sell |
41,039
-23,372
| -36% | -$1.72M | ﹤0.01% | 3821 |
|
|
2025
Q1 | $4.66M | Sell |
64,411
-18,112
| -22% | -$1.52M | ﹤0.01% | 3425 |
|
|
2024
Q4 | $7.32M | Buy |
82,523
+133
| +0.2% | +$11.9K | ﹤0.01% | 3074 |
|
|
2024
Q3 | $6.97M | Buy |
82,390
+3,007
| +4% | +$267K | ﹤0.01% | 3056 |
|
|
2024
Q2 | $7.34M | Buy |
79,383
+40,242
| +103% | +$4.07M | ﹤0.01% | 2808 |
|
|
2024
Q1 | $4.42M | Buy |
39,141
+17,541
| +81% | +$1.75M | ﹤0.01% | 3205 |
|
|
2023
Q4 | $2.01M | Sell |
21,600
-1,110
| -5% | -$97.7K | ﹤0.01% | 3926 |
|
|
2023
Q3 | $2.08M | Buy |
22,710
+2,349
| +12% | +$252K | ﹤0.01% | 3742 |
|
|
2023
Q2 | $2.47M | Sell |
20,361
-2,075
| -9% | -$224K | ﹤0.01% | 3708 |
|
|
2023
Q1 | $2.2M | Sell |
22,436
-4,543
| -17% | -$433K | ﹤0.01% | 3783 |
|
|
2022
Q4 | $2.19M | Buy |
26,979
+5,190
| +24% | +$435K | ﹤0.01% | 3873 |
|
|
2022
Q3 | $1.66M | Sell |
21,789
-3,269
| -13% | -$314K | ﹤0.01% | 4125 |
|
|
2022
Q2 | $2.74M | Sell |
25,058
-10,676
| -30% | -$1.13M | ﹤0.01% | 3762 |
|
|
2022
Q1 | $3.55M | Sell |
35,734
-18,672
| -34% | -$1.78M | ﹤0.01% | 3671 |
|
|
2021
Q4 | $5.2M | Buy |
54,406
+35,771
| +192% | +$3.59M | ﹤0.01% | 3373 |
|
|
2021
Q3 | $2.06M | Sell |
18,635
-45,225
| -71% | -$5.15M | ﹤0.01% | 4173 |
|
|
2021
Q2 | $7.4M | Buy |
63,860
+34,253
| +116% | +$3.94M | ﹤0.01% | 2990 |
|
|
2021
Q1 | $3.08M | Sell |
29,607
-1,430
| -5% | -$178K | ﹤0.01% | 3563 |
|
|
2020
Q4 | $3.73M | Sell |
31,037
-27,356
| -47% | -$2.76M | ﹤0.01% | 3235 |
|
|
2020
Q3 | $5.07M | Buy |
58,393
+6,357
| +12% | +$547K | ﹤0.01% | 2888 |
|
|
2020
Q2 | $4.22M | Sell |
52,036
-43,941
| -46% | -$3.2M | ﹤0.01% | 2925 |
|
|
2020
Q1 | $6.62M | Buy |
95,977
+57,814
| +151% | +$6.1M | ﹤0.01% | 2418 |
|
|
2019
Q4 | $4.36M | Buy |
38,163
+6,665
| +21% | +$830K | ﹤0.01% | 3064 |
|
|
2019
Q3 | $4.11M | Buy |
31,498
+3,687
| +13% | +$480K | ﹤0.01% | 3009 |
|
|
2019
Q2 | $3.41M | Sell |
27,811
-30,228
| -52% | -$3.47M | ﹤0.01% | 3144 |
|
|
2019
Q1 | $6.1M | Buy |
58,039
+8,876
| +18% | +$954K | ﹤0.01% | 2813 |
|
|
2018
Q4 | $5.03M | Sell |
49,163
-4,647
| -9% | -$516K | ﹤0.01% | 2870 |
|
|
2018
Q3 | $6.38M | Sell |
53,810
-3,260
| -6% | -$368K | ﹤0.01% | 2794 |
|
|
2018
Q2 | $5.48M | Buy |
57,070
+15,570
| +38% | +$1.44M | ﹤0.01% | 2901 |
|
|
2018
Q1 | $3.37M | Buy |
41,500
+9,924
| +31% | +$769K | ﹤0.01% | 3209 |
|
|
2017
Q4 | $2.28M | Buy |
31,576
+12,231
| +63% | +$834K | ﹤0.01% | 3675 |
|
|
2017
Q3 | $1.19M | Buy |
+19,345
| New | +$1.18M | ﹤0.01% | 4430 |
|
|
2017
Q2 | – | Sell |
-12,278
| Closed | -$802K | – | 6984 |
|
|
2017
Q1 | $802K | Sell |
12,278
-11,386
| -48% | -$807K | ﹤0.01% | 4583 |
|
|
2016
Q4 | $1.66M | Buy |
23,664
+5,121
| +28% | +$326K | ﹤0.01% | 4021 |
|
|
2016
Q3 | $1.16M | Buy |
18,543
+8,865
| +92% | +$547K | ﹤0.01% | 4274 |
|
|
2016
Q2 | $583K | Sell |
9,678
-6,399
| -40% | -$351K | ﹤0.01% | 4711 |
|
|
2016
Q1 | $800K | Buy |
16,077
+2,721
| +20% | +$135K | ﹤0.01% | 4284 |
|
|
2015
Q4 | $717K | Buy |
+13,356
| New | +$669K | ﹤0.01% | 4612 |
|
|
2015
Q3 | – | Sell |
-10,700
| Closed | -$586K | – | 7499 |
|
|
2015
Q2 | $586K | Sell |
10,700
-4,023
| -27% | -$199K | ﹤0.01% | 5025 |
|
|
2015
Q1 | $699K | Buy |
14,723
+5,687
| +63% | +$242K | ﹤0.01% | 4809 |
|
|
2014
Q4 | $379K | Buy |
9,036
+3,223
| +55% | +$127K | ﹤0.01% | 5549 |
|
|
2014
Q3 | $206K | Sell |
5,813
-5,809
| -50% | -$205K | ﹤0.01% | 6137 |
|
|
2014
Q2 | $397K | Sell |
11,622
-8,019
| -41% | -$259K | ﹤0.01% | 5520 |
|
|
2014
Q1 | $679K | Sell |
19,641
-5,453
| -22% | -$181K | ﹤0.01% | 5016 |
|
|
2013
Q4 | $885K | Sell |
25,094
-21,310
| -46% | -$698K | ﹤0.01% | 4840 |
|
|
2013
Q3 | $1.44M | Buy |
46,404
+6,834
| +17% | +$202K | ﹤0.01% | 4233 |
|
|
2013
Q2 | $1.09M | Buy |
+39,570
| New | +$1.05M | ﹤0.01% | 4319 |
|
Other funds holding USPH
BG
CCM
SAM
Goldman Sachs's USPH Position: Q2 2026 in Review
Goldman Sachs reduced its US Physical Therapy (USPH) stake by 28% in Q2 2026, selling an estimated $1.99M and leaving 74,441 shares worth $5.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3859.
Goldman Sachs first reported a position in USPH in Q2 2013 and has held it in 51 quarters since. The position peaked at $7.77M in Q1 2026. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.
- Goldman Sachs held 74,441 shares of US Physical Therapy worth $5.11M as of Q2 2026.
- Goldman Sachs sold 29,267 US Physical Therapy shares in Q2 2026, an estimated $1.99M.
- US Physical Therapy made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3859 holding.
- Goldman Sachs first reported a position in US Physical Therapy in Q2 2013 and has held it in 51 quarters since.
- Goldman Sachs's US Physical Therapy position peaked at $7.77M in Q1 2026.
- 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.